ABOUT MEDTRACE PHARMA

We are a development stage company aiming to innovate PET diagnostic imaging.

Contact us

Our team

Martin Stenfeldt

CEO

Linkedin-in
Rune Wiik Kristensen

Chief Operational Officer

Linkedin-in

Dorte Thulstrup

VP, Regulatory Affairs & Quality assurance

Linkedin-in
Hans Harms, Ph.D.

VP, aQuant Development

Karina Kück

coordinator, Regulatory affairs & quality assurance

Linkedin-in

Kasper Lykkegaard Therkelsen

Design & usability lead

Linkedin-in

Teresa Lorrio Gonzales

SOFTWARE DEVELOPer

Linkedin-in

Mark Gockenbach

Coordinator, SoftWare deployment

Linkedin-in

Yumi Murakami

Country manager japan

Linkedin-in
Lars Poulsen Tolbod, Ph.D.

New indications specialist

Peter Larsen, Ph.D.

Advisor, hardware development

Linkedin-in
Jens Soerensen, M.D., Professor

clinical advisor

Group 7Created with Sketch.

Mark Lubberink, Professor

scientific advisor

Helle Rasmussen

Bookkeeper

Rebekka Stenfeldt

STUDENT ASSISTANT,
BUSINESS SUPPORT

Our board of directors

Ulrik Spork

Chairman

Linkedin-in
Mads Rasmussen

Vice-chairman

Linkedin-in
Group 7Created with Sketch.
Michael Frank

Director

Linkedin-in

Bernt Skov Jensen

Director

Linkedin-in
Jens Soerensen, M.D., Professor

Director & CMO

Group 6Created with Sketch.

”The availability of a reliable approved system for bed-side production of 15O-water could change 15O-water PET from an exotic research tool to a clinical workhorse”

Martin Stenfeldt, CEO, MedTrace Pharma